Psoriasis : (Record no. 91316)

MARC details
000 -LEADER
fixed length control field 04623cam a2200517 i 4500
001 - CONTROL NUMBER
control field ocn854433627
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128212333.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130315s2013 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2019713767
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781626185852
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1626185859
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1626185840
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781626185845
035 ## - SYSTEM CONTROL NUMBER
System control number 608841
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)854433627
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 017000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Psoriasis :
Subtitle types, triggers, and treatment strategies
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical,
Date of production, publication, distribution, manufacture, or copyright notice [2013]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 0# - SERIES TITLE
Series statement Dermatology--laboratory and clinical research
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents PSORIASIS ; Library of Congress Cataloging-in-Publication Data ; Contents ; Preface ; Chapter 1 Keratinocytes in Psoriasis: Key Players in the Disease Process ; Abstract ; I. Skin Homeostasis and Regulation of Function; II. Psoriasis ; 1. Epidemiology ; 2. Clinical Features ; 3. Psoriasis and the Quality of Life; 4. Psoriasis-Associated Co-Morbidities ; 5. Histologic Features ; 6. Psoriasis Phenotypes ; Classification of Psoriasis According to the Clinical Phenotype ; I. Chronic Plaque Psoriasis ; II. Inverse Psoriasis ; III. Guttate Psoriasis ; IV. Erythrodermic Psoriasis.
505 8# - CONTENTS
Contents V. Childhood Psoriasis VI. Pustular Psoriasis ; VII. Nail disease (Psoriatic Onychodystrophy) ; VIII. Psoriatic Arthritis (PsA) ; 7. Therapeutic Armamentarium ; i. Topical Therapy ; ii. Phototherapy ; Ultraviolet B Radiation (UVB) ; Acute ; Chronic ; iii. Systemic Therapy ; Etanercept is Discussed Below as A Representative of this Class of Biologic Therapies; 8. The Mystery of the Disease Origin ; 9. Emerging Drugs; The Controversial Role of DMF; Conclusion; References ; Chapter 2 Types, Triggers and Treatment Strategies of Psoriasis ; Abstract ; Introduction ; Triggering Factors.
505 8# - CONTENTS
Contents Infections Drugs ; Cutaneous Traumas ; Stress and Psychosomatic Factors ; Alcohol ; Smoking ; Clinical Variants ; Psoriasis Vulgaris-Chronic Plaque Psoriasis ; Guttate Psoriasis ; Small Plaque Psoriasis ; Inverse Psoriasis; Seborrhoeic Psoriasis ; Scalp Psoriasis ; Palmoplantar (Non Pustular) Psoriasis ; Nail Psoriasis ; Mucous Membranes ; Pustular Psoriasis ; Erythrodermic Psoriasis ; Treatment; General Considerations ; Topical Treatments ; Corticosteroids; Vitamin D Analogues ; Tazarotene; Salicylic Acid ; Topical Calcineurin Inhibitors ; Anthralin; Coal Tar ; Phototherapy.
505 8# - CONTENTS
Contents UVB Phototherapy Photochemotherapy; Systemic Oral Agents ; Methotrexate; Acitretin ; Cyclosporine ; Other Systemic Drugs; Biologics ; Alefacept ; Efalizumab ; Adalimumab; Etanercept ; Infliximab ; Ustekinumab ; Conclusion ; References ; Chapter 3 A New Strategy for the Treatment of Psoriasis: Keratin 17 (K17) -- Targeting Therapy ; Abstract ; Introduction ; 1. Keratin 17; 1.1. Expression and Location of Keratin 17 ; 1.2. Functions of Keratin 17; 1.3. Keratin 17 as an Immune Regulator ; 2. Keratin 17 and Psoriasis ; 2.1. Expression of K17 in Psoriasis.
505 8# - CONTENTS
Contents 2.2. K17 and Psoriasis-Associated Cytokines 2.2.1. Regulation of K17 Expression by IFN- ; 2.2.2. Regulation of K17 Expression by IL-17 and IL-22 ; 2.2.3. Signal-Regulated Kinase Pathway of K17 Expression ; 2.3. Impact of K17 on Psoriatic Autoreactive T Cells ; 2.3.1. Classic Antigens of Psoriatic T Cells in Different Types of Psoriasis; 2.3.2. Sequences in K17 Serving As Psoriatic T Cell-Epitopes ; 2.3. K17 and Autoimmune Positive Feedback Loops in Psoriasis ; 3. K17 and Treatment of Psoriasis ; 3.1. Treatments in Psoriasis ; 3.2. K17 in the Treatments of Psoriasis.
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050
650 #0 - SUBJECT HEADINGS
Subject term Psoriasis.
9 (RLIN) 7575
700 1# - ADDED PERSONAL NAME
Added personal author Smith, Phillip B.
700 1# - ADDED PERSONAL NAME
Added personal author Johnson, Nathan C.
Titles and other words associated with a name (Dermatologist)
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=608841">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=608841</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 10368082
938 ## -
-- EBSCOhost
-- EBSC
-- 608841
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3022679
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=608841 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice